| Study inclusion | Prior to RT | During RT | At the end of RT | 3 weeks after RT | OP: 4–6 weeks after RT | 6 weeks after RT | 3 months after OP | 6 months after OP | 9 months after OP | 12 months after OP |
---|---|---|---|---|---|---|---|---|---|---|---|
Inclusion and exclusion criteria | x | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â |
Informed consent | x | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â |
Medical history | x | Â | x | x | x | Â | x | x | x | x | x |
Evaluation of symptoms and toxicity | x | Â | x | x | x | Â | x | x | x | x | x |
Radiotherapy | Â | Â | x | Â | Â | Â | Â | Â | Â | Â | Â |
Resection | Â | Â | Â | Â | Â | x | Â | Â | Â | Â | Â |
MRI abdomen/pelvis | Â | x | Â | Â | x | Â | Â | x | x | x | x |
CT thorax | Â | x | Â | Â | Â | Â | Â | x | x | x | x |
Quality of life (QLQ-C30) | Â | x | Â | Â | x | Â | Â | x | Â | Â | x |